2024
DOI: 10.1111/tid.14322
|View full text |Cite
|
Sign up to set email alerts
|

Impact of COVID‐19 monoclonal antibodies on outcomes of COVID‐19 infection in hematopoietic stem cell transplant and chimeric antigen receptor therapy recipients

Elizabeth H Hahn,
Hong Li,
Craig S Sauter
et al.

Abstract: BackgroundHematopoietic stem cell transplant (HSCT) and chimeric antigen receptor T‐cell therapy (CAR‐T) recipients are at higher risk of serious complications of COVID‐19 infection than the general population. Though there is evidence that monoclonal antibodies (MCA) against COVID‐19 reduce the risk of death and hospitalization in the general population, data regarding their efficacy in HSCT and CAR‐T recipients remains scarce.MethodsWe conducted a retrospective review of HSCT and CAR‐T recipients to compare … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
references
References 43 publications
0
0
0
Order By: Relevance